<SEC-DOCUMENT>0001178913-25-001590.txt : 20250506
<SEC-HEADER>0001178913-25-001590.hdr.sgml : 20250506
<ACCEPTANCE-DATETIME>20250506072810
ACCESSION NUMBER:		0001178913-25-001590
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		2
CONFORMED PERIOD OF REPORT:	20250506
FILED AS OF DATE:		20250506
DATE AS OF CHANGE:		20250506

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			IM Cannabis Corp.
		CENTRAL INDEX KEY:			0001792030
		STANDARD INDUSTRIAL CLASSIFICATION:	MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				000000000
		STATE OF INCORPORATION:			A1
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-40065
		FILM NUMBER:		25915238

	BUSINESS ADDRESS:	
		STREET 1:		KIBBUTZ GLIL YAM
		CITY:			CENTRAL DISTRICT
		STATE:			L3
		ZIP:			4690500
		BUSINESS PHONE:		416-256-4202

	MAIL ADDRESS:	
		STREET 1:		KIBBUTZ GLIL YAM
		CITY:			CENTRAL DISTRICT
		STATE:			L3
		ZIP:			4690500
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>zk2533116.htm
<DESCRIPTION>6-K
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: company
         Document created using Broadridge PROfile 25.2.1.5287
         Copyright 1995 - 2025 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">
  <font style="font-family: 'Times New Roman',Times,serif;">
  </font>
  <div>
    <hr align="center" style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;">
    <div>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: center; line-height: 1.25;"><font style="font-weight: bold;">UNITED STATES</font><br>
        <font style="font-size: 14pt; font-family: 'Times New Roman',Times,serif; font-weight: bold;">SECURITIES AND EXCHANGE COMMISSION</font><br>
        <font style="font-family: 'Times New Roman',Times,serif;">Washington, D.C. 20549<br style="line-height: 1.25;">
        </font></div>
      <div style="text-align: center; line-height: 1.25;"><font style="font-family: 'Times New Roman',Times,serif;"><br>
          </font></div>
      <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-size: 14pt;"><font style="font-weight: bold;">Form 6-K</font></div>
      <div style="text-align: center; line-height: 1.25;"><font style="font-family: 'Times New Roman',Times,serif;"><font style="font-weight: bold;"></font><br>
          </font></div>
      <div style="text-align: center; line-height: 1.25;"><font style="font-family: 'Times New Roman',Times,serif;"><font style="font-weight: bold;">REPORT OF FOREIGN
            PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16</font><br>
          <font style="font-weight: bold;">UNDER THE SECURITIES EXCHANGE ACT OF 1934</font></font></div>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
      <div style="text-align: center; line-height: 1.25;">For the month of <font style="font-weight: bold;"><u>May 2025</u></font>.</div>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
      <div style="text-align: center; line-height: 1.25;">Commission File Number: <font style="font-weight: bold;"><u>001-40065</u></font></div>
      <div style="text-align: center; line-height: 1.25;"><br>
        <font style="font-size: 16pt; font-weight: bold;"><u>IM Cannabis Corp.</u></font><br>
        (Exact Name of Registrant as Specified in Charter)<br>
        <br>
        <font style="font-weight: bold;"><u>Kibbutz Glil Yam, Central District, Israel 4690500</u></font><br>
        (Address of principal executive offices)</div>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;">Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.</div>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: center; line-height: 1.25;">Form 20-F &#9746;&#160;&#160;&#160; Form 40-F &#9744;</div>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;">Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ____</div>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;"><font style="font-weight: bold;">Note</font><font style="font-family: 'Times New Roman',Times,serif;">: Regulation S-T Rule 101(b)(1) only permits the submission in paper of a Form 6-K if submitted solely to provide an attached annual report to security holders.</font></div>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;">Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ____</div>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;"><font style="font-weight: bold;">Note</font><font style="font-family: 'Times New Roman',Times,serif;">: Regulation S-T Rule 101(b)(7) only permits the submission in paper of a Form 6-K if submitted to furnish a report or other document that the registrant foreign private issuer must furnish and make
          public under the laws of the jurisdiction in which the registrant is incorporated, domiciled or legally organized (the registrant's "home country"), or under the rules of the home country exchange on which the registrant's securities are traded,
          as long as the report or other document is not a press release, is not required to be and has not been distributed to the registrant's security holders, and, if discussing a material event, has already been the subject of a Form 6-K submission or
          other Commission filing on EDGAR.</font></div>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: center; line-height: 1.25; font-weight: bold;">SIGNATURE</div>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to
        be signed on its behalf by the undersigned, thereunto duly authorized.</div>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
      <table cellspacing="0" cellpadding="0" border="0" id="zf9b516c501d9404e9b5c37e4c6711cf3" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 4%; vertical-align: middle; font-family: 'Times New Roman',Times,serif;">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 46%; vertical-align: middle; font-family: 'Times New Roman',Times,serif;">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
            <td style="vertical-align: middle; font-family: 'Times New Roman',Times,serif;" colspan="2">
              <div style="line-height: 1.25; font-weight: bold;">IM CANNABIS CORP.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 4%; vertical-align: middle; font-family: 'Times New Roman',Times,serif;">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 46%; vertical-align: middle; font-family: 'Times New Roman',Times,serif;">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
            <td style="vertical-align: middle; font-family: 'Times New Roman',Times,serif;" colspan="2">
              <div style="line-height: 1.25;">(Registrant)</div>
            </td>
          </tr>
          <tr>
            <td style="width: 4%; vertical-align: middle; font-family: 'Times New Roman',Times,serif;">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 46%; vertical-align: middle; font-family: 'Times New Roman',Times,serif;">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 5%; vertical-align: middle; font-family: 'Times New Roman',Times,serif;">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 44.53%; vertical-align: middle; font-family: 'Times New Roman',Times,serif;">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
          </tr>
          <tr>
            <td style="width: 4%; vertical-align: middle; font-family: 'Times New Roman',Times,serif;">
              <div style="line-height: 1.25;">Date:</div>
            </td>
            <td style="width: 46%; vertical-align: middle; font-family: 'Times New Roman',Times,serif;">
              <div style="line-height: 1.25;">May 6, 2025</div>
            </td>
            <td style="width: 5%; vertical-align: middle; font-family: 'Times New Roman',Times,serif;">
              <div style="line-height: 1.25;">By:</div>
            </td>
            <td style="width: 44.53%; vertical-align: middle; border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">
              <div style="line-height: 1.25; font-style: italic;">/s/ Oren Shuster</div>
            </td>
          </tr>
          <tr>
            <td style="width: 4%; vertical-align: middle; font-family: 'Times New Roman',Times,serif;">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 46%; vertical-align: middle; font-family: 'Times New Roman',Times,serif;">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 5%; vertical-align: middle; font-family: 'Times New Roman',Times,serif;">
              <div style="line-height: 1.25;">Name:</div>
            </td>
            <td style="width: 44.53%; vertical-align: middle; font-family: 'Times New Roman',Times,serif;">
              <div style="line-height: 1.25;">Oren Shuster</div>
            </td>
          </tr>
          <tr>
            <td style="width: 4%; vertical-align: middle; font-family: 'Times New Roman',Times,serif;">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 46%; vertical-align: middle; font-family: 'Times New Roman',Times,serif;">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 5%; vertical-align: middle; font-family: 'Times New Roman',Times,serif;">
              <div style="line-height: 1.25;">Title:</div>
            </td>
            <td style="width: 44.53%; vertical-align: middle; font-family: 'Times New Roman',Times,serif;">
              <div style="line-height: 1.25;">Chief Executive Officer and Director</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: center; line-height: 1.25; font-weight: bold;"><u>EXHIBIT INDEX</u></div>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
      <table cellspacing="0" cellpadding="0" border="0" id="z43f8bb1c92644480aa955af85f9a7cb1" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 6%; vertical-align: middle; background-color: rgb(204, 238, 255); font-family: 'Times New Roman',Times,serif;">
              <div style="line-height: 1.25;"><a href="exhibit_99-1.htm">99.1</a></div>
            </td>
            <td style="width: 94%; vertical-align: middle; background-color: rgb(204, 238, 255); font-family: 'Times New Roman',Times,serif;">
              <div style="line-height: 1.25;"><a href="exhibit_99-1.htm">News Release dated May 6, 2025</a></div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;"><br style="line-height: 1.25;">
      </div>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">
        <hr align="center" style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"></div>
    </div>
  </div>
  <font style="font-family: 'Times New Roman',Times,serif;">
  </font>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>exhibit_99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: company
         Document created using Broadridge PROfile 25.2.1.5287
         Copyright 1995 - 2025 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <hr align="center" style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;">
    <div style="text-align: right;"><u><font style="font-weight: bold;"> Exhibit 99.1</font></u><br>
    </div>
    <div> <br>
    </div>
    <div>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-size: 12pt; font-weight: bold;">IM Cannabis to Report First Quarter 2025 Financial Results on Thursday, May 15<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">th</sup> at 9:00am ET</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;"><font style="font-weight: bold;">TORONTO and GLIL YAM, Israel, May 6,
          2025</font>&#160;-- IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the "<font style="font-weight: bold;">Company</font>",
        "<font style="font-weight: bold;">IMCannabis</font>", or "<font style="font-weight: bold;">IMC</font>"), a leading medical
        cannabis company with operations in Israel and Germany, will report operational and financial results for the first quarter 2025 ended March 31, 2025, on Thursday, May 15, 2025, before the market opens.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;">The Company will host a zoom web conference on the same day at 9:00am ET to discuss the results, followed by a question-and-answer
        session for the investment community. Investors are invited to register by clicking <u>here</u>. All relevant information will be sent upon registration.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;">If you are unable to join us live, a recording of the call will be available on our website at <u>https://investors.imcannabis.com</u> within 24 hours after the call.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="line-height: 1.25;">Link for the zoom call: <u>https://us02web.zoom.us/j/82140859987?pwd=bMnLyv9nV9C0vyIttzmLGrWmhkR5nY.1</u></div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; line-height: 1.25; font-weight: bold;">About IM Cannabis Corp.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;">IMC (Nasdaq: IMCC) (CSE: IMCC) is an international cannabis company that provides premium cannabis products to medical patients in
        Israel and Germany, two of the largest medical cannabis markets. The Company&#8217;s focus is to achieve sustainable and profitable growth in its highest value markets, Israel and Germany. The Company leverages a transnational ecosystem powered by a
        unique data-driven approach and a globally sourced product supply chain. With an unwavering commitment to responsible growth and compliance with the strictest regulatory environments, the Company strives to amplify its commercial and brand power to
        become a global high-quality cannabis player.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;">The IMC ecosystem operates in Israel through its commercial relationship with Focus Medical Herbs Ltd., which imports and distributes
        cannabis to medical patients, leveraging years of proprietary data and patient insights. The Company also operates medical cannabis retail pharmacies, online platforms, distribution centers, and logistical hubs in Israel that enable the safe
        delivery and quality control of IMC products throughout the entire value chain. In Germany, the IMC ecosystem operates through Adjupharm GmbH, where it distributes cannabis to pharmacies for medical cannabis patients.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="line-height: 1.25;">Company Contact:</div>
      <br>
      <div style="line-height: 1.25;">Anna Taranko, Director Investor &amp; Public Relations</div>
      <div style="line-height: 1.25;">IM Cannabis Corp.</div>
      <div style="line-height: 1.25;">+49 157 80554338</div>
      <div style="line-height: 1.25;"><u>a.taranko@imcannabis.de</u></div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="line-height: 1.25;">Oren Shuster, CEO</div>
      <div style="line-height: 1.25;">IM Cannabis Corp.</div>
      <div style="line-height: 1.25;">+972-77-3603504</div>
      <div style="line-height: 1.25;"><u>info@imcannabis.com</u></div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="line-height: 1.25;">
        <hr align="center" style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"></div>
    </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
